Posts Tagged ‘Peter Kolchinsky RA Capital Management’

Peter Kolchinsky, Ra Capital Management Open Position in Xencor Inc (XNCR)

Peter Kolchinsky
Peter Kolchinsky and Ra Capital Management are betting big on Xencor Inc (NASDAQ:XNCR). In a recent filing with the Securities and Exchange Commission......(read more)

Sunesis Pharmaceuticals, Inc. (SNSS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Is Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) a healthy stock for your portfolio? Money managers are turning bullish. The number of bullish hedge fund......(read more)

Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)

Keryx Biopharmaceuticals (NASDAQ:KERX)
Keryx Biopharmaceuticals (NASDAQ:KERX) investors should pay attention to an increase in enthusiasm from smart money in recent months. In today’s marketplace......(read more)

Here is What Hedge Funds Think About Senomyx Inc. (SNMX)

Peter Kolchinsky
Senomyx Inc. (NASDAQ:SNMX) investors should be aware of a decrease in activity from the world’s largest hedge funds recently. If you’d ask......(read more)

Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)

Peter Kolchinsky
Antares Pharma Inc (NASDAQ:ATRS) investors should pay attention to an increase in activity from the world’s largest hedge funds recently. In the......(read more)

Hedge Funds Are Selling XOMA Corp (XOMA)

XOMA Corp (NASDAQ:XOMA)
XOMA Corp (NASDAQ:XOMA) investors should pay attention to a decrease in hedge fund interest lately. If you’d ask most investors, hedge funds are......(read more)

Hedge Funds Are Crazy About Novavax, Inc. (NVAX): Obagi Medical Products, Inc. (OMPI), Vical Incorporated (VICL)

Peter Kolchinsky
Novavax, Inc. (NASDAQ:NVAX) was in 5 hedge funds’ portfolio at the end of December. NVAX investors should pay attention to an increase in hedge......(read more)

Here is What Hedge Funds Think About Insmed Incorporated (INSM): Threshold Pharmaceuticals, Inc. (THLD), Repligen Corporation (RGEN)

Peter Kolchinsky
Is Insmed Incorporated (NASDAQ:INSM) a first-rate stock to buy now? The smart money is getting more bullish. The number of long hedge fund bets rose by......(read more)

Hedge Funds Are Dumping Sunesis Pharmaceuticals, Inc. (SNSS): Curis, Inc. (CRIS), Repros Therapeutics Inc (RPRX)

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Is Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) ready to raly soon? Prominent investors are getting less bullish. The number of bullish hedge fund bets......(read more)

Is ArQule, Inc. (ARQL) Going to Burn These Hedge Funds?: ShangPharma Corp (ADR) (SHP), OncoGenex Pharmaceuticals Inc (OGXI)

ArQule, Inc. (NASDAQ:ARQL)
ArQule, Inc. (NASDAQ:ARQL) was in 13 hedge funds’ portfolio at the end of December. ARQL investors should pay attention to a decrease in hedge fund......(read more)

Hedge Funds Bought and Sold These Stocks

Steven Cohen
Hedge funds that take a large percentage stake in public companies, or then change the size of their stake in the future (including by selling shares)......(read more)

Hedge Fund News: Lee Robinson, Mitt Romney, Procter & Gamble

The Procter & Gamble Company (NYSE:PG)
June losses weigh heavy on Robinson’s Altana (eFinancialNews) Altana Wealth, the Monaco-based hedge fund firm set up by Lee Robinson, saw its two......(read more)

3 New Bets by A Biotech Hedge Fund

Peter Kolchinsky
Founded in 2002, PeterKolchinsky’sRACapitalManagement invests in a number of small-cap biotech start ups, priding itself in its “evidence-based”......(read more)

Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT

Peter Kolchinsky
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT). According to a regulatory filing, now RA Capital Management......(read more)

Peter Kolchinsky’s RA Capital Management Reported Stakes In $DYAX, $POZN, And $SQNM

Peter Kolchinsky
Peter Kolchinsky’s RA Capital Management reported its passive stake in Dyax Corp (DYAX), Pozen Inc. /NC (POZN), and Sequenom Inc. (SQNM) on December......(read more)

Raging Capital Took Activist Stake in Derma Sciences

Peter Kolchinsky
Raging Capital filed on November 29th for its 13.5% activist stake in Derma Sciences, Inc. (DSCI). Raging Capital is one of DSCI’s insider. According......(read more)

Peter Kolchinsky’s RA Capital Management Bet on $GNTA

Peter Kolchinsky
Peter Kolchinsky’s RA Capital Management revealed on October 5th that it initiated a brand new position of 42.93 million shares in Genta Incorporated......(read more)
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!